Incidence of bowel perforation in gastrointestinal lymphomas by location and histology

Por Vaidya, R., Witzig, T. E.
Publicado em 2014

Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era

Por Vaidya, R., Witzig, T. E.
Publicado no Ann Oncol (2014)

Signal Transduction Inhibitor Therapy for Lymphoma

Por Witzig, Thomas E., Gupta, Mamta
Publicado em 2010

Waldenström Macroglobulinemia

Por Ghobrial, Irene M., Witzig, Thomas E.
Publicado em 2004

Initial therapy of mantle cell lymphoma

Por Inwards, David J., Witzig, Thomas E.
Publicado em 2011

A Novel Missense (M206K) STAT3 Mutation in Diffuse Large B Cell Lymphoma Deregulates STAT3 Signaling

Por Hu, Guangzhen, Witzig, Thomas E., Gupta, Mamta
Publicado em 2013

Recurrent acute inflammatory demyelinating polyradiculoneuropathy following R-CHOP treatment for non-Hodgkin lymphoma

Por Liang, Jackson J., Singh, Preet P., Witzig, Thomas E.
Publicado em 2013

Targeting the PD-1 pathway in patients with relapsed classic Hodgkin lymphoma following allogeneic stem cell transplant is safe and effective

Por Villasboas, Jose Caetano, Ansell, Stephen M., Witzig, Thomas E.
Publicado no Oncotarget (2016)

Targeted therapy in lymphoma

Por Johnston, Patrick B, Yuan, RuiRong, Cavalli, Franco, Witzig, Thomas E
Publicado em 2010

Epstein-Barr Virus Infection in an Elderly Nonimmunocompromised Adult Successfully Treated with Rituximab

Por Smeltzer, Jacob P., Howard, Matthew T., Gonsalves, Wilson I., Witzig, Thomas E.
Publicado em 2014

Lack of JAK2 Activating Non-synonymous Mutations In Diffuse Large B Cell Tumors: JAK2 Deregulation Still Unexplained

Por Witzig, Thomas E., Price-Troska, Tammy, Stenson, Mary J., Gupta, Mamta
Publicado em 2012

Intratumoral CD4(+)CD25(+) regulatory T-cell-mediated suppression of infiltrating CD4(+) T cells in B-cell non-Hodgkin lymphoma

Por Yang, Zhi-Zhang, Novak, Anne J., Stenson, Mary J., Witzig, Thomas E., Ansell, Stephen M.
Publicado em 2006

CD70(+) non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4(+)CD25(−) T cells

Por Yang, Zhi-Zhang, Novak, Anne J., Ziesmer, Steven C., Witzig, Thomas E., Ansell, Stephen M.
Publicado em 2007

Attenuation of CD8(+) T-Cell Function by CD4(+)CD25(+) Regulatory T Cells in B-Cell Non-Hodgkin's Lymphoma

Por Yang, Zhi-Zhang, Novak, Anne J., Ziesmer, Steven C., Witzig, Thomas E., Ansell, Stephen M.
Publicado em 2006

Malignant B Cells Skew the Balance of Regulatory T Cells and T(H)17 Cells in B-Cell Non-Hodgkin’s Lymphoma

Por Yang, Zhi-Zhang, Novak, Anne J., Ziesmer, Steven C., Witzig, Thomas E., Ansell, Stephen M.
Publicado em 2009

Single-Agent Rituximab for Primary CNS Lymphoma During Pregnancy As a Bridge to Definitive Management

Por Burnette, Brian L., Jentoft, Mark A., Porrata, Luis F., Boyce, Thomas G., Witzig, Thomas E.
Publicado em 2014

Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2

Por Gupta, Mamta, Ansell, Stephen M., Novak, Anne J., Kumar, Shaji, Kaufmann, Scott H., Witzig, Thomas E.
Publicado em 2009

Pseudo-monoclonal gammopathy: a report of four cases

Por Jawad, Majd D., Go, Ronald S., Witzig, Thomas E., Mikhael, Joseph R., Ravindran, Aishwarya, Murrray, David L.
Publicado no Haematologica (2017)

Immunosuppressive CD14(+)HLA-DR(low/−) monocytes in B-cell non-Hodgkin lymphoma

Por Lin, Yi, Gustafson, Michael P., Bulur, Peggy A., Gastineau, Dennis A., Witzig, Thomas E., Dietz, Allan B.
Publicado em 2011

CDDO-imidazolide mediated inhibition of malignant cell growth in Waldenström macroglobulinemia

Por Elsawa, Sherine F., Novak, Anne J., Grote, Deanna, Konopleva, Marina, Andreeff, Michael, Witzig, Thomas E., Ansell, Stephen M.
Publicado em 2008